Literature DB >> 34342022

Alcohol use and dysglycemia among people living with human immunodeficiency virus (HIV) in the Alcohol & Metabolic Comorbidities in PLWH: Evidence Driven Interventions (ALIVE-Ex) study.

Stefany D Primeaux1,2, Liz Simon1,3, Tekeda F Ferguson3,4, Danielle E Levitt1,3, Meghan M Brashear1,3, Alice Yeh1, Patricia E Molina1,3.   

Abstract

BACKGROUND: At-risk alcohol use is a common and costly form of substance misuse that is highly prevalent among people living with HIV (PLWH). The goal of the current analysis was to test the hypothesis that PLWH with at-risk alcohol use are more likely to meet the clinical criteria for prediabetes/diabetes than PLWH with low-risk alcohol use.
METHODS: A cross-sectional analysis was performed on measures of alcohol and glycemic control in adult PLWH (n = 105) enrolled in a prospective, interventional study (the ALIVE-Ex Study (NCT03299205)) that investigated the effects of aerobic exercise on metabolic dysregulation in PLWH with at-risk alcohol use. The Alcohol Use Disorders Identification Test (AUDIT), Timeline Followback, and phosphatidylethanol (PEth) level were used to measure alcohol use. Participants were stratified into low-risk (AUDIT score < 5) and at-risk alcohol use (AUDIT  score ≥ 5). All participants underwent an oral glucose tolerance test and measures of glycemic control- the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and Matsuda Index - were correlated with alcohol measures and compared by AUDIT score group using mixed-effects linear and logistic regression models, adjusting for age, sex, race, body mass index (BMI), and viral load.
RESULTS: In response to the glucose challenge, participants with at-risk alcohol use (n = 46) had higher glucose levels and were five times more likely to meet criteria for prediabetes/diabetes (OR: 5.3 (1.8, 15.9)) than participants with an AUDIT score < 5. Two-hour glucose values were positively associated with AUDIT score and PEth level and a higher percentage of PLWH with at-risk alcohol use had glucose values ≥140 mg/dl than those with low-risk alcohol use (34.8% vs. 10.2%, respectively).
CONCLUSION: In this cohort of PLWH, at-risk alcohol use increased the likelihood of meeting the clinical criteria for prediabetes/diabetes (2-h glucose level ≥140 mg/dl). Established determinants of metabolic dysfunction (e.g., BMI, waist-hip ratio) were not associated with greater alcohol use and dysglycemia, suggesting that other mechanisms may contribute to the impaired glycemic control observed in this cohort.
© 2021 Research Society on Alcoholism.

Entities:  

Keywords:  HIV; OGTT; at-risk alcohol use; dysglycemia; glycemic control

Mesh:

Substances:

Year:  2021        PMID: 34342022      PMCID: PMC8547613          DOI: 10.1111/acer.14667

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.928


  58 in total

1.  Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT.

Authors:  Andrea Tura; Alexandra Kautzky-Willer; Giovanni Pacini
Journal:  Diabetes Res Clin Pract       Date:  2005-12-01       Impact factor: 5.602

2.  Ethanol feeding impairs insulin-stimulated glucose uptake in isolated rat skeletal muscle: role of Gs alpha and cAMP.

Authors:  Qiang Wan; Yi Liu; Qingbo Guan; Ling Gao; Kok Onn Lee; Jiajun Zhao
Journal:  Alcohol Clin Exp Res       Date:  2005-08       Impact factor: 3.455

Review 3.  Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.

Authors:  Absalon D Gutierrez; Ashok Balasubramanyam
Journal:  Endocrine       Date:  2011-12-02       Impact factor: 3.633

4.  High Prevalence of Metabolic Syndrome and Cardiovascular Disease Risk Among People with HIV on Stable ART in Southwestern Uganda.

Authors:  Daniel Muyanja; Conrad Muzoora; Anthony Muyingo; Winnie Muyindike; Mark J Siedner
Journal:  AIDS Patient Care STDS       Date:  2015-12-18       Impact factor: 5.078

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.

Authors:  Todd T Brown; Stephen R Cole; Xiuhong Li; Lawrence A Kingsley; Frank J Palella; Sharon A Riddler; Barbara R Visscher; Joseph B Margolick; Adrian S Dobs
Journal:  Arch Intern Med       Date:  2005-05-23

Review 7.  Adiponectin and alcoholic fatty liver disease.

Authors:  Christopher Q Rogers; Joanne M Ajmo; Min You
Journal:  IUBMB Life       Date:  2008-12       Impact factor: 3.885

8.  Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy.

Authors:  Bernardo Lombo; Imran Alkhalil; Marjorie P Golden; Irma Fotjadhi; Sreedhar Ravi; Michael Virata; Marta Lievano; Jose Diez; Andre Ghantous; Thomas Donohue
Journal:  Conn Med       Date:  2015-05

9.  Differential contribution of chronic binge alcohol and antiretroviral therapy to metabolic dysregulation in SIV-infected male macaques.

Authors:  Stephen M Ford; Liz Simon Peter; Paul Berner; Garth Cook; Curtis Vande Stouwe; Jason Dufour; Gregory Bagby; Steve Nelson; Patricia E Molina
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-07-24       Impact factor: 4.310

10.  Glucose tolerance and B cell function in chronic alcoholism: its relation to hepatic histology and exocrine pancreatic function.

Authors:  B N Andersen; C Hagen; O K Faber; J Lindholm; P Boisen; H Worning
Journal:  Metabolism       Date:  1983-11       Impact factor: 8.694

View more
  2 in total

1.  Unique circulating microRNA associations with dysglycemia in people living with HIV and alcohol use.

Authors:  Brianna L Bourgeois; Hui-Yi Lin; Alice Y Yeh; Danielle E Levitt; Stefany D Primeaux; Tekeda F Ferguson; Patricia E Molina; Liz Simon
Journal:  Physiol Genomics       Date:  2021-12-03       Impact factor: 4.297

Review 2.  Pathophysiological Consequences of At-Risk Alcohol Use; Implications for Comorbidity Risk in Persons Living With Human Immunodeficiency Virus.

Authors:  Liz Simon; Scott Edwards; Patricia E Molina
Journal:  Front Physiol       Date:  2022-01-18       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.